By Scott Gottlieb (original source The Wall Street Journal)
“The Covid epidemic in the South has strained the country’s capacity to keep up with the demand for testing. Six months into the pandemic, we still don’t have enough supplies, equipment or lab services. There’s no national plan for effectively allocating the capacity that does exist or providing a sufficient surge where it’s needed suddenly.
The system is overwhelmed. Major commercial labs are reporting turnaround times of around seven days, and patients say it’s often longer. Without a confirmed diagnosis, many infected patients don’t isolate themselves or get treatments.
The intelligence community has warned for years that pandemic disease was a national-security threat on par with that of terrorism, weapons of mass destruction and cyberattacks. It’s essential to increase American capacity to detect these events, contain them, and manufacture reliable countermeasures.”
Click here to read more
Leana Wen: How long does covid booster protection last?
More evidence highlighting the benefit, and limitations, of covid-19 vaccines. After the Centers for Disease Control and Prevention shifted its coronavirus vaccine guidance from a…
Thought Leader: Leana Wen
Dr. Sanjay Gupta: How Wearable Tech Transforms Health
We’ve come a long way in integrating technology into our daily lives, but could wearable tech actually help you live longer? From detecting heartbeat irregularities to flagging signs of…
Thought Leader: Sanjay Gupta
Annie Leibovitz Celebrated Women Alongside Her Many Muses
Annie Leibovitz has captured some of fashion’s most indelible images over the past five decades—oftentimes for this magazine. Many of those photographs—from Queen Elizabeth II…
Thought Leader: Annie Leibovitz
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb
